Cancer vaccines, T-cell engineering and drug resistance take center stage at ICABS 2026 in Taiwan
Researchers at ICABS 2026 explored personalized cancer vaccines, T-cell therapy, and treatment resistance. Key findings included the development of neoantigen-based vaccines and immune cell metabolism, as well as strategies targeting tumor vulnerabilities.